These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9075163)

  • 61. Successful use of Fendrix in HIV-infected non-responders to standard hepatitis B vaccines.
    de Silva TI; Green ST; Cole J; Stone BJ; Dockrell DH; Vedio AB
    J Infect; 2014 Apr; 68(4):397-9. PubMed ID: 24384506
    [No Abstract]   [Full Text] [Related]  

  • 62. Acute hepatitis B infection after vaccination.
    Burns SM; Molyneaux PJ
    Lancet; 1995 Jan; 345(8944):262; author reply 262-3. PubMed ID: 7734020
    [No Abstract]   [Full Text] [Related]  

  • 63. Immunogenicity of hepatitis B vaccine incorporated into the expanded program of immunization schedule.
    Gomber S; Sharma R; Ramachandran VG; Talwar V; Singh B
    Indian Pediatr; 2000 Apr; 37(4):411-3. PubMed ID: 10781235
    [No Abstract]   [Full Text] [Related]  

  • 64. Response of Egyptian infants with protein calorie malnutrition to hepatitis B vaccination.
    el-Gamal Y; Aly RH; Hossny E; Afify E; el-Taliawy D
    J Trop Pediatr; 1996 Jun; 42(3):144-5. PubMed ID: 8699579
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Oral vaccines--a future prospect! Hepatitis vaccination in the vegetable market?].
    Stiefelhagen P
    MMW Fortschr Med; 2003 Nov; 145(47):10. PubMed ID: 14725025
    [No Abstract]   [Full Text] [Related]  

  • 66. Acute hepatitis B infection after vaccination.
    Goffin E; Horsmans Y; Cornu C; Geubel A; Pirson Y
    Lancet; 1995 Jan; 345(8944):263. PubMed ID: 7823747
    [No Abstract]   [Full Text] [Related]  

  • 67. The role of the GAVI Alliance in improving childhood hepatitis B vaccination in China: successes, lessons learned, and future global challenges.
    Averhoff F; Kolwaite A; Ward JW
    Vaccine; 2013 Dec; 31 Suppl 9():J5-7. PubMed ID: 23623862
    [No Abstract]   [Full Text] [Related]  

  • 68. [A nested case control study for risk factors impacting hepatitis B vaccination in Hebei, China].
    Ma JC; Han CZ; Qi SX; Tian C; Li J; Zhao SJ; Zhang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):201-4. PubMed ID: 19031703
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The importance of a preschool booster for children born to hepatitis B-positive mothers.
    Ladhani SN; Ramsay ME
    Arch Dis Child; 2013 Jun; 98(6):395-6. PubMed ID: 23625988
    [No Abstract]   [Full Text] [Related]  

  • 70. [Vaccination. Hepatitis B].
    Braun R; Kimmig P; Hassler D
    Dtsch Med Wochenschr; 2002 May; 127(20):1062. PubMed ID: 12051190
    [No Abstract]   [Full Text] [Related]  

  • 71. [Hepatitis B is an occupational risk for health personnel. Preventive vaccination is recommended].
    Struve J; Aronsson B; Forsgren M; Frenning B; von Sydow M; Weiland O
    Lakartidningen; 1996 Mar; 93(10):884-8. PubMed ID: 8656790
    [No Abstract]   [Full Text] [Related]  

  • 72. A comparison of low vs standard dose intramuscularly administered hepatitis B vaccine.
    Venkatesan EA; Mathai D; Samuel BU; John TJ
    J Assoc Physicians India; 1994 Jun; 42(6):461-2. PubMed ID: 7852229
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hepatitis B immunization coverage and risk behaviour among Danish travellers: are immunization strategies based on single journey itineraries rational?
    Sonder G; van den Hoek A
    J Infect; 2010 Apr; 60(4):309-10; author reply 310-11. PubMed ID: 20100513
    [No Abstract]   [Full Text] [Related]  

  • 74. A systematic review and meta-analysis of management options for adults who respond poorly to hepatitis B vaccination.
    David MC; Ha SH; Paynter S; Lau C
    Vaccine; 2015 Nov; 33(48):6564-9. PubMed ID: 26424603
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunogenicity and safety of yeast-derived recombinant hepatitis B vaccine (Heberbiovac HB) in South African children.
    Mphahlele MJ; Burnett RJ; Kyaw T; Schoeman HS; Aspinall S
    S Afr Med J; 2004 Apr; 94(4):280-1. PubMed ID: 15150941
    [No Abstract]   [Full Text] [Related]  

  • 76. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serologic response to hepatitis B vaccination in children with isolated anti-Hbc.
    Atabek ME; Erkul I
    J Trop Pediatr; 2006 Feb; 52(1):71-2. PubMed ID: 15917263
    [No Abstract]   [Full Text] [Related]  

  • 78. Factors associated with vaccination against hepatitis B in adolescents and young adults from an urban settlement.
    Guimarães RA; Matos MA
    Braz J Infect Dis; 2015; 19(3):332-3. PubMed ID: 25911089
    [No Abstract]   [Full Text] [Related]  

  • 79. Entry to medical school: by examination and vaccination?
    Lancet; 1994 Apr; 343(8903):927-8. PubMed ID: 7909002
    [No Abstract]   [Full Text] [Related]  

  • 80. [Comment on the contribution by F. Zipp and K. P. Wandinger. Current recommendations for vaccinations in multiple sclerosis].
    Rieckmann P; Moriabadi N; Flachenecker P; Toyka K
    Nervenarzt; 2001 Dec; 72(12):972. PubMed ID: 11789446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.